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ABSTRACT 
Hyperhomocysteinaemia has been linked in various studies worldwide to the occurrence of cardiovascular 
disorders and endothelial cell injury.  In Nigeria with one of the highest maternal/neonatal mortality and 
morbidity, it is significant to explore means of predicting pregnancy-induced hypertension. This study was 
carried out at the Lagos University Teaching Hospital which is a major referral center in the South-western 
part of Nigeria. It was set to determine the mean plasma homocysteine levels and corpuscular haemoglobin 
in pre-eclamptic/eclamptic Nigerian women. A total of 150 subjects consisting of 100 primigravidae and 25 
diagnosed cases of pre-eclampsia/eclampsia and 25 non-pregnant females were enrolled in the study. 60 
primigravidae were lost to follow up or had incomplete data. The mean value of homocysteine in the control 
group, and eclamptic group was 7.5±3.4 µmol/L and 16.1±6.5 µmol/L respectively. There is positive and 
significant correlation between plasma homocysteine in the eclamptic group and the mean MCV (r=0.97, 
p=0.01), and between plasma homocysteine, systolic and diastolic blood pressure of the eclamptic group 
(r=0.944, p=0.0001; r=0.98, p=0.0001). The study further supports earlier findings of increased 
homocysteine levels in the occurrence of pre-eclampsia/eclampsia.  
 
Keywords: Hyperhomocysteinaemia, Pre-eclampsia/eclampsia, Primigravidae, Cardiovascular 
disorder 
 
Received 25 May 2009/ Accepted 31 July 2009 
 
INTRODUCTION  
Hypertensive disorders in pregnancy (pre-
eclampsia/eclampsia) are among the leading 
causes of maternal mortality worldwide 
accounting for approximately 17% of all maternal 
deaths (Keinth, 1999). Overall perinatal mortality 
in pre-eclampsia is about 35/1000 total births, but 
may reach 160/1000 births in severe cases. Pre-
eclampsia complicates 3-5% of first pregnancy 
and 1-2% of subsequent pregnancies with about 
5-10% of cases being severe (Keinth, 1999). 
Hyperhomocysteinaemia has been linked in 
various studies worldwide to the occurrence of 
cardiovascular disorders, and endothelial cell 
injury (Holmes et al., 2005).  
 
Epidemiological studies worldwide have also 
demonstrated strong correlation between 
homocysteine levels in the blood and 
cardiovascular diseases, and wide spectrum of 
thromboembolic disorders (Mas Valerie, 2003). 
The theoretical background for this study of the 
relationship between hyperhomocysteinaemia and 
pre-eclampsia/eclampsia, is based on the 
understanding that when the enzyme reactions 
involved in the two metabolic pathways of 
homocysteine metabolism are impaired, or there 
are nutritional deficiencies of vitamins such as 
folate, vitamin B12, and vitamin B6, these may 
manifest clinically as widespread endothelial 
damage with laboratory evidence of increasing 
mean corpuscular volume (MCV).
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However, current research efforts are being 
directed at the 677C→T polymorphism in the 
MTHFR gene, with some studies documenting 
higher values of total plasma homocysteine 
among subjects with TT genotype compared with 
those with the CC genotypic variant (up to 16% in 
some studies).  These genetic variants, together 
with dietary and other geographical factors could 
be responsible for ethnic and racial variations in 
plasma homocysteine levels worldwide (Rajkovic 
et al., 2004).   
 
This study was carried out in Lagos, which is 
known to be the most populated city in Nigeria 
and the most representative of the multi-ethnic 
background of the nation. However, only few data 
exists (from Northern Nigeria) on this subject 
matter (Cotter et al., 2001). The challenges of 
management, and difficulty in predicting possible 
pregnancy outcome in the face of dwindling 
resources, where folate, vitamin B12 assay and 
genetic studies are not immediately feasible. This 
study therefore attempts to document baseline 
values and possible predictive values for 
occurrence of pre-eclampsia/eclampsia using 
plasma homocysteine levels and mean 
corpuscular volume in pregnant females. 
 
MATERIALS AND METHODS  
Study Centre, Population and Design 
This study was carried out among 100 
primigravidae attending the ante-natal clinic of the 
Lagos University Teaching Hospital, Idi-Araba 
between January to October 2006. The hospital is 
located in the South West region of Nigeria and 
serves as a referral center serving the most 
populated and ethnically diverse state in Nigeria. 
The participants were all those presenting at the 
clinic in the month of January 2006, who 
voluntarily agreed to participate in the study and 
were registered for the first time at less than 
fourteen weeks of gestation. Twenty-five (25) 
clinically diagnosed cases of eclampsia were also 
recruited for the study which was the total number 
of cases admitted in the study center between 
January and October 2006. With 25 non-pregnant 
females randomly selected as control, all 
primigravidae with history of hypertension, 
diabetes mellitus, renal disease, deranged 
urinalysis report, use of alcoholic beverage and 
smoking were excluded to limit study bias. All 
participants were to strictly maintain the drug 
regimen prescribed for routine antenatal use only.  
 
 
Ethical approval for the study was obtained from 
the hospital ethical committee.  
 
Collection of Samples and Analysis 
On collection of 4.5ml of venous blood in EDTA 
bottle, plasma levels of homocysteine were 
determined at the time of registration, at 26 weeks 
and at 34 weeks of gestation respectively for all 
participants, and on all the twenty-five (25) cases 
of eclampsia using the enzyme linked immuno-
assay technique (Diazyme Laboratories, San-
Diego, USA), which has a high level of precision, 
with a total coefficient of variation of 4.5 - 7.4% 
and a turnover of 82 samples for 2.5 hours. 
Quality control sample was run with each batch of 
test. Estimation of Mean cell volume (MCV) was 
carried out on 4.5ml of venous blood in EDTA 
bottle using the electronic coulter counter (ADVIA-
TM 60). Supine blood pressure readings were 
taking and urinalysis done on each participant 
using the dry chemistry method. 
 
Data Analysis 
The data was analysed using the statistical 
software SPSS version 11 (SPSS Inc, Chicago). 
The data on qualitative variable were indicated by 
frequency and percentage, qualitative variables 
by range and mean, and association. Verified by 
Chi-Square with statistically significant value 
placed at P<0.05. 
 
RESULTS 
A total of 150 subjects were enrolled in the study, 
this consisted of 100 primigravidae and 25 
diagnosed cases of eclampsia and 25 non-
pregnant females (Table 1). Sixty (60) 
primigravidae were either lost to follow up or had 
incomplete data. Mean ages of respondents were 
25±5.8 years for control group, 27±5.8years for 
primigravidae and 28 ± 4.6 years for the pre-
eclamptic/eclamptic study group. Mean value of 
homocysteine in the control group was 7.5±3.4 
µmol/L. Mean values of plasma homocysteine 
declined progressively throughout pregnancy 
among the primigravidae (7.1±2.9µmol/L; 6.0±1.7 
µmol/L and 5.4±1.7 µmol/L for 1st, 2nd and 3rd   
trimester respectively).  
 
As shown in table 1, there was marked elevation 
of plasma homocysteine in the eclamptic subjects 
which ranged from 11.6µmol/L to 38.5µmol/L with 
a mean value of 16.1 ± 6.5µmol/L. The mean 
corpuscular volume for the eclamptic group 
(85±6.6fl) was significantly higher than those for  
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the non-pregnant control, and primigravidae 
throughout pregnancy (80±4.3fl, p=0.032 and 




Positive and significant correlation exists between 
the plasma homocysteine levels among the 
eclamptic group and MCV of respondents in that 
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There was a statistically significant association 
between rising homocysteine level in the 
eclamptic group and blood pressure levels (Table 
2). The mean systolic and diastolic blood 
pressure within the group (177±29 mmHg; 
110±17 mmHg respectively) correlates well with 
mean plasma homocysteine levels (r=0.944, 
p=0.0001; r = 0.98; p=0.0001). The mean plasma 
homocysteine level in the 3rd trimester of normal 
pregnancy was significantly different from that of 
the eclampatic group at the third trimester of 
pregnancy (5.4 ± 1.7µmol/L and 16.1 ± 6.5µmol/L 
respectively, p=0.048 and 0.014). The relative risk 
for developing pre-eclampsia/eclampsia in this 
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Numerous studies have been done on 
homocysteine and its association with toxemia of 
pregnancy. Makedos et al. (2007) in the study of 
28 pre-eclamptic patients and 26 normal control 
subjects gave a recorded value of 11.11µmol/L 
and 6.40µmol/L for pre-eclamptic and normal 
control respectively. This is not much different 
from that obtained in this study (16.1µmol/L and 
7.5µmol/L respectively). However, they found no 
significant difference in the plasma folate and 
vitamin B12 of both groups. The mean value of 
plasma tHcy of 16.1 ± 6.5µmol/L in this study, 
showed a significant elevation when compared 
with mean third trimester value of 5.4±1.7 µmol/L 
in the primigravidae (p=0.00), thus putting the 
relative risk of developing pre-eclampsia at 7.7.  
 
A similar study by Cotter et al. (2001) however 
recorded a lower value of 9.8 µmol/L in some 
patients with pregnancy induced hypertension in 
Northern Nigeria. Megahad and Taher in a study 
of 25 subjects with eclampsia, reported a decline 
in the value of red cell folate among the 
respondents, but no significant difference in the 
levels of plasma vitamin B12 (Megahad and 
Taher, 2004). 
 
Michelle et al. (2002) documented a progressive 
fall in plasma homocysteine level throughout 
pregnancy irrespective of use or non-use of folic 
acid in pregnancy. This may imply that subtle 
folate deficiency, or defect in folate metabolic 
pathway is a more important variable in the 
pathogenesis of hyperhomocysteinaemia. Current 
studies however are aimed at 677 (C→T) gene 
polymorphism to establish new aetiological 
relationship between rising plasma homocysteine 
level and folate metabolism. A study of 356 
subjects in Zimbabwe found that one subject with 
pre-eclampsia had homozygous 677(C→T) gene 
even though this association was not statistically 
significant (Tanya et al., 1999).  
 
Similarly, Angius et al. (2007) attributed lower 
values of tHcy seen among Burkinabes to a more 
effective homocysteine metabolism.  
 
Geographical and racial variations in plasma 
homocysteine have also been documented. Peter 
et al. (2004) documented a significantly lower 
plasma homocysteine among pregnant white 
females (5.5 µmol/L), compared to black pregnant 
females (7.6 µmol/L), and reported that though 
plasma homocysteine levels where elevated in 
subjects with pre-eclampsia, the black pre-
eclamptic females still had a higher mean plasma 
homocysteine levels. This, they attributed to racial 
difference in diet and adherence to folic acid 
supplement. However, this finding is at variance 
with those of Moore et al. (2006) in a racial 
comparison study of 158 non-pregnant females 
and 12 pregnant Gambian women, with their 
female British counterpart. They recorded a mean 
plasma homocysteine level of 9.0 µmol/L in non-
pregnant female Gambians and a lower value of 
6.2 µmol/L in the pregnant females. These values 
approximated well with those of their British 
counterpart (9.4 µmol/L for non-pregnant white 
females). Findings in this study agree with those 
from the Gambian studies. 
 
Agyemang and Bhopal (2005) recorded higher 
blood pressure and Body Mass Index (BMI) 
among women of African origin in the UK. 
However, homocysteine level correlated poorly 
with systolic and diastolic blood pressure of 
respondents in the control group and throughout 
pregnancy in normal pregnant respondents (r= -
0.065/-0.70, p>0.05, r=0.064/0.10, p>0.05). In this 
study, there was a strong correlation between the 
homocysteine level and the systolic/diastolic 
blood pressure in the eclamptic group (r=0.944, 
p=0.0001; r = 0.98; p=0.0001). Of the 40 
primigravidae that was followed up, one of the 
respondents showed a rising pattern of plasma 
homocysteine throughout the 1st to 3rd trimester of 




17.0µmol/L respectively). The pre-registration 
value of blood pressure rose from 120/80mmHg 
at 14 weeks) to 140/90mmHg at 34 weeks with 
associated proteinuria. These imply that in health, 
homocysteine has no correlation with blood 
pressure, until homocysteine level rises to a point 
where it induces widespread endothelial damage, 
vasospasm and microangiopathic changes with 
subsequent elevation of blood pressure. However, 
despite earlier submission by Michelle et al. 
(2002) and Makedos et al. (2007) on the relative 
insignificant difference in folate and vitamin B12 
levels between the pre-eclamptic and normal 
control study groups, the observed significant 
difference in the mean corpuscular volume seen 
in the eclamptic group (mean MCV value of 
85±6.6/L) and those of the non-pregnant controls 
(80±4.3/L, p <0.05) might be attributable to subtle 
nutritional deficiencies in folate and vitamin B12 
metabolism (Mueller et al., 2001).   
  
CONCLUSION 
This study has been able to document the pattern 
of plasma homocysteine among pregnant 
Nigerian women in the Southwestern part of the 
country, and cases of pre-eclampsia/eclampsia. It 
has further provided possible predictive value for 
increasing mean corpuscular volume, plasma 
homocysteine level and rising blood pressure 
during pregnancy as a prelude to the 
development of pre-eclampsia/eclampsia. 
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